LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

Home・Akcijų sąrašas・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

34.23 -3.06

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

34.23

Max

34.23

Pagrindiniai rodikliai
By Trading Economics
Pajamos	11M 51M
Pardavimai	39M 239M
P/E Sektoriaus vid.	11.36 110.024
Pelnas, tenkantis vienai akcijai	1.08
Pelno marža	21.242
Darbuotojai	268
EBITDA	14M 73M

Rekomendacijos
By TipRanks
Rekomendacijos	Stiprus pirkimas
12 mėnesių prognozė	+40.3% upside

Dividendai
By Dow Jones
Kitas uždarbis	2026-02-24

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	387M 2.1B
Ankstesnė atidarymo kaina	37.29
Ankstesnė uždarymo kaina	34.23

Naujienos nuotaikos

By Acuity

50%

159 / 351 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bullish Evidence

29.8 / N/A Palaikymas ir pasipriešinimas

Harmony Biosciences Holdings Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-02-20 17:37; UTC

Įsigijimai, susijungimai, perėmimai

Paramount Regulatory Waiting Period for Warner Bid Expires -- Update

2026-02-20 16:18; UTC

Pagrindinės rinkos jėgos

Footwear Stocks Rise After Supreme Court Strikes Down Tariffs

2026-02-20 23:12; UTC

Įsigijimai, susijungimai, perėmimai

FERC Authorizes TXNM Energy Acquisition by Blackstone Infrastructure

2026-02-20 22:12; UTC

Uždarbis

Equinox Gold: Announces Filing of 2025 Audited Fincl Statements

2026-02-20 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-02-20 21:50; UTC

Rinkos pokalbiai

Auto & Transport Roundup: Market Talk

2026-02-20 21:23; UTC

Uždarbis

These Stocks Are Today's Movers: Grail, Corning, Comfort Systems USA, Opendoor, Akamai, Chemours, and More -- Barrons.com

2026-02-20 21:20; UTC

Rinkos pokalbiai

Century Aluminum Backs Trump's Tariffs After SCOTUS Ruling -- Market Talk

2026-02-20 21:01; UTC

Įsigijimai, susijungimai, perėmimai

Want to Win the Warner Bros. Discovery Takeover Battle? 'Walk Away Now.' -- Barrons.com

2026-02-20 20:38; UTC

Rinkos pokalbiai

U.S. Natural Gas Gains Ahead of Chilly Weekend -- Market Talk

2026-02-20 20:17; UTC

Rinkos pokalbiai

Oil Futures Mixed As Market Awaits U.S.-Iran Moves -- Market Talk

2026-02-20 20:11; UTC

Rinkos pokalbiai

Traders Await Word on USMCA Exemption For Trump's Global 10% Tariff -- Market Talk

2026-02-20 19:59; UTC

Rinkos pokalbiai

U.S. Tariff Ruling Could Make Things Worse for Mexico -- Market Talk

2026-02-20 19:58; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Netflix Seen as Not Needing Warner Bros. Deal -- Market Talk

2026-02-20 19:49; UTC

Rinkos pokalbiai

Mexico's Revised 4Q GDP Expected to Confirm Pick-Up -- Market Talk

2026-02-20 19:09; UTC

Rinkos pokalbiai

Precious Metals Settle Higher After Tariff Ruling -- Market Talk

2026-02-20 19:00; UTC

Rinkos pokalbiai

U.S. Oil, Gas Rig Counts Unchanged on Week -- Market Talk

2026-02-20 18:28; UTC

Rinkos pokalbiai

Ontario Premier Warns Fight Against U.S. Tariffs Isn't Over -- Market Talk

2026-02-20 18:20; UTC

Rinkos pokalbiai

Tariff Ruling Seen Positive for Some Retailers, Mixed for Others -- Market Talk

2026-02-20 18:05; UTC

Rinkos pokalbiai

Market Talk Roundup: Latest on U.S. Politics

2026-02-20 18:04; UTC

Rinkos pokalbiai

Trade Uncertainty in Canada to Remain Until USMCA Resolved -- Market Talk

2026-02-20 17:38; UTC

Rinkos pokalbiai

Canada's Small Firms Look Toward Increased U.S. Tariff Opposition -- Market Talk

2026-02-20 17:24; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-02-20 17:24; UTC

Rinkos pokalbiai

Correction to Treasury Yields Fall Market Talk

2026-02-20 17:20; UTC

Rinkos pokalbiai

Financial Services Roundup: Market Talk

2026-02-20 16:53; UTC

Rinkos pokalbiai

Market Talk Roundup: Latest on U.S. Politics

2026-02-20 16:53; UTC

Rinkos pokalbiai

Canada Dollar Steady, Market Focus on USMCA Review -- Market Talk

2026-02-20 16:45; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-02-20 16:45; UTC

Rinkos pokalbiai

U.K. Public Finances Supportive of Gilts in Near-Term -- Market Talk

2026-02-20 16:40; UTC

Rinkos pokalbiai

Trade Threats Facing Canada Not Removed by Supreme Court's Ruling -- Market Talk

Akcijų palyginimas

Kainos pokytis

Harmony Biosciences Holdings Inc Prognozė

Kainos tikslas

By TipRanks

40.3% į viršų

12 mėnesių prognozė

Vidutinis 48.25 USD 40.3%

Aukščiausias 55 USD

Žemiausias 42 USD

Remiantis 5 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Harmony Biosciences Holdings Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

5 ratings

Pirkti

Laikyti

Parduoti

Remiantis 5 analitikų, pateikusių Harmony Biosciences Holdings Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

29.8 / N/APalaikymas ir pasipriešinimas

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Rinkos nuotaikos

By Acuity

159 / 351 reitingas Sveikatos priežiūra

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.